CDC Recommends Patients Stop Using EzriCare Artificial Tears Products Pending Additional Guidance For These OTC Eye Drops
(Posted by Tom Lamb at Drug Injury Watch)
On February 1, 2023, the US Centers for Disease Control and Prevention
Drug Injury Watch
Blog Authors
Latest from Drug Injury Watch
Valtrex Associated With Serious Skin Reaction DRESS Side Effect That Can Be Fatal, Says Health Canada
By Tom Lamb
Canadian Product Monograph for Valtrex Now Warns About Risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
(Posted by Tom Lamb at Drug Injury Watch)
Valtrex (valacyclovir) is a long-established treatment for cold sores, genital herpes,…
Tepezza Hearing Loss: Cases of This Drug Side Effect Reviewed in Various Medical Journal Articles
By Tom Lamb
This Treatment for Thyroid Eye Disease Was Approved by FDA in 2020, With Hearing Problems Reported Soon Thereafter
(Posted by Tom Lamb at Drug Injury Watch)
We recently wrote about Tepezza hearing loss cases in this October…
Tepezza Hearing Side Effects Include Hearing Loss, Resulting in Tepezza Drug Injury Lawsuits
By Tom Lamb
Tepezza Hearing Loss May be Irreversible and Permanent, Continuing Even After Patient Stops Using Tepezza
(Posted by Tom Lamb at Drug Injury Watch)
Tepezza is a relatively new treatment for Thyroid Eye Disease, approved by the FDA…
Copiktra Risk-Benefit Profile Update Following the Recent September 2022 FDA Advisory Committee Meeting
By Tom Lamb
Issue: Whether Copiktra Risk-Benefit Profile is Still Favorable as a Third-Line CLL/SLL Cancer Treatment; Final Vote: “No”
(Posted by Tom Lamb at Drug Injury Watch)
We concluded our July 5, 2022 article, “Using Copiktra for Leukemia…
Byetta, Trulicity, Ozempic, and Adlyxin Linked to Gallbladder Disease Side Effects, Including Deaths
By Tom Lamb
36 Cases of Acute Cholecystitis in Patients Taking Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in FDA FAERS
(Posted by Tom Lamb at Drug Injury Watch)
A recent Research Letter written by three FDA employees with the Center for…
Off-Topic News: Camp Lejeune Lawsuits for Cancers due to Contaminated Water During 1953-1987 Now Allowed
By Tom Lamb
People Need to File a Federal Court Lawsuit in the Eastern District of North Carolina Before August 8, 2024 Filing Deadline
(Posted by Tom Lamb at Drug Injury Watch)
Veterans who served at Camp Lejeune and their…
Off-Topic Alert: Breast Implants Lymphoma Cancer ALCL Case Numbers Increasing Rapidly in the US
By Tom Lamb
New Estimates Reported in July 2022 Medical Journal Article Reveal BIA-ALCL is Diagnosed More Often as Time Goes On
(Posted by Tom Lamb at Drug Injury Watch)
A research letter published July 21, 2022 in JAMA Oncology,…
Using Copiktra for Leukemia or Lymphoma May Increase Risks of Serious Side Effects and Death
By Tom Lamb
Future FDA Advisory Committee Meeting Will Discuss Whether Copiktra Should be Used as CLL or SLL Treatment
(Posted by Tom Lamb at Drug Injury Watch)
As background, Copiktra (duvelisib) was approved by the FDA in 2018 to…
Xalkori Vision Disorders for Pediatric Patients in Clinical Trials Seen at Alarming Rate, Says EMA
By Tom Lamb
Drug Safety Warning: Ocular Toxicity and Severe Visual Loss Associated With Xalkori is Difficult to Detect in Children
(Posted by Tom Lamb at Drug Injury Watch)
Xalkori (crizotinib) is approved by the FDA for the treatment of:…